Hendry, S., Parry, O., Ku, K. P. (2026). Treatment decision-making after CAR-T and bispecific antibody therapy in relapsed/refractory multiple myeloma: Real-world perspectives from U.S. hematologist/oncologists.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.e19525